Return to homepagePandemic Pact

(Theme 5) Anti-cancer therapies and COVID-19

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-364

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Samra Tjuralic

  • Research Location

    United Kingdom

  • Lead Research Institution

    Francis Crick Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

Projects within this theme aim to understand the specific risks for vulnerable populations, including the interaction of SARS-CoV-2 infection with different types of cancer and with specific treatment modalities. It will address: the impact of underlying health conditions, the impact of anti-cancer interventions on the course of COVID-19 and protecting vulnerable populations in hospital.